Inventor · disambiguated record
Ellen Chi
Also filed as: CHI ELLEN
28 granted patents·9 pending applications·85 citations·filing 2004–2024
96Inventor score
Files withJANSSEN BIOTECH INC15JANSSEN PHARMACEUTICA NV12CHI ELLEN3JANSSEN SCIENCES IRELAND UNLIMITED CO2SWANSON RONALD V2
Top patents by PatentIndex Score
37 records- 0197US11767354B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Sep 26, 2023·3 cites·23 claims
- 0296US10428134B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 1, 2019·7 cites·21 claims
- 0395US11591379B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 28, 2023·3 cites·20 claims
- 0494US10968265B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 6, 2021·4 cites·24 claims
- 0594US10787495B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Sep 29, 2020·3 cites·20 claims
- 0694US10640544B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 5, 2020·4 cites·28 claims
- 0793US11401315B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Aug 2, 2022·2 cites·24 claims
- 0893US10858413B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Dec 8, 2020·3 cites·17 claims
- 0992US2025026803A1Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1089US8951525B2Human tissue factor antibody and uses thereofJANSSEN BIOTECH INC·Filed 2013·Granted Feb 10, 2015·11 cites·17 claims
- 1189US8722044B2Human tissue factor antibody and uses thereofALMAGRO JUAN CARLOS·Filed 2012·Granted May 13, 2014·12 cites·19 claims
- 1288US8999333B2Human tissue factor antibody and uses thereofJANSSEN BIOTECH INC·Filed 2014·Granted Apr 7, 2015·9 cites·15 claims
- 1387US8399630B2Engineered anti-IL-13 antibodies, compositions, methods and usesSWANSON RONALD V·Filed 2009·Granted Mar 19, 2013·11 cites·5 claims
- 1486US2023365644A1Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide y receptorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1585US10759854B2Interferon alpha and omega antibody antagonistsJANSSEN BIOTECH INC·Filed 2019·Granted Sep 1, 2020·2 cites·13 claims
- 1683US8323646B2Engineered anti-IL-13 antibodies, compositions, methods and usesSWANSON RONALD V·Filed 2009·Granted Dec 4, 2012·7 cites·3 claims
- 1778US12134636B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 5, 2024·0 cites·35 claims
- 1878US10208113B2Interferon α and ω antibody antagonistsJANSSEN BIOTECH INC·Filed 2015·Granted Feb 19, 2019·2 cites·19 claims
- 1977US2024117000A1Glucagon like peptide 1 (glp-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereofJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2023·Application pending·0 cites
- 2076US10358491B2Interferon alpha and omega antibody antagonistsJANSSEN BIOTECH INC·Filed 2018·Granted Jul 23, 2019·1 cites·8 claims
- 2169US11746157B2PSMA binding agents and uses thereofJANSSEN BIOTECH INC·Filed 2019·Granted Sep 5, 2023·1 cites·81 claims
- 2265US11780900B2Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereofJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Oct 10, 2023·0 cites·27 claims
- 2363US10875902B2Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Dec 29, 2020·0 cites·30 claims
- 2461US9902770B2Interferon alpha and omega antibody antagonistsJANSSEN BIOTECH INC·Filed 2014·Granted Feb 27, 2018·0 cites·15 claims
- 2560US2025179196A1Materials and methods of making or using il-23r binding proteinsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 2659US10155809B2Interferon alpha and omega antibody antagonistsJANSSEN BIOTECH INC·Filed 2017·Granted Dec 18, 2018·0 cites·4 claims
- 2756US10179808B2Kv1.3 antagonists and methods of useJANSSEN BIOTECH INC·Filed 2014·Granted Jan 15, 2019·0 cites·12 claims
- 2856US2019135912A1Interferon Alpha and Omega Antibody AntagonistsJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 2955US12162951B2Anti-idiotypic antibodies against anti-KLK2 antibodiesJANSSEN BIOTECH INC·Filed 2021·Granted Dec 10, 2024·0 cites·29 claims
- 3055US7241604B1Crystallization of 11-Beta-Hydroxysteroid Dehydrogenase type 1TAKEDA SAN DIEGO INC·Filed 2004·Granted Jul 10, 2007·0 cites·9 claims
- 3153US8759067B2Polynucleotides encoding engineered plant cysteine proteases and their usesCHI ELLEN·Filed 2013·Granted Jun 24, 2014·0 cites·6 claims
- 3252US2011091971A1Differentiation of Pluripotent Stem CellsDAVIS JANET·Filed 2009·Application pending·0 cites
- 3351US12030937B2Anti-idiotypic antibodies against anti-GPRC5D antibodiesJANSSEN BIOTECH INC·Filed 2021·Granted Jul 9, 2024·0 cites·30 claims
- 3451US2019062383A1Kv1.3 Antagonists and Methods of UseJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 3550US2024218083A1Molecules with engineered antibody constant region variantsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 3649US8426186B2Engineered potato virus A nuclear inclusion proteinCHI ELLEN·Filed 2011·Granted Apr 23, 2013·0 cites·3 claims
- 3735US2015087812A1Human Autotaxin Antibodies and Methods of UseCHI ELLEN·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ellen Chi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →